Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection (Q33384442)

26 July 2017

Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection (English)

1 reference

26 July 2017

1 reference

Xiang Gao

1

1 reference

26 July 2017

Kun Cai

2

1 reference

26 July 2017

Jing Shi

3

1 reference

26 July 2017

Hao Liu

4

1 reference

26 July 2017

Xiaojun Hou

5

1 reference

26 July 2017

Wei Tu

6

1 reference

26 July 2017

Le Xiao

7

1 reference

26 July 2017

Qin Wang

8

1 reference

26 July 2017

Hui Wang

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

2 February 2009

1 reference

26 July 2017

1 reference

26 July 2017

27

1 reference

26 July 2017

14

1 reference

26 July 2017

2070-2076

1 reference

Laboratory diagnosis of verotoxin-producing Escherichia coli infections

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Infection by verocytotoxin-producing Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Role of verotoxin receptors in pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Immunoprophylactic potential of cloned Shiga toxin 2 B subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Development of DNA vaccines against hemolytic-uremic syndrome in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

7 January 2021

Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

7 January 2021

Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

7 January 2021

Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.115

7 January 2021

10.1016/J.VACCINE.2009.01.115

Identifiers

DOI

1 reference

26 July 2017

1 reference